Senior Editor, Consumer Health
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Malcolm Spicer
The length of exclusivity periods is the only major difference between pending US House and Senate bills, both largely based on a proposal developed by FDA and drug industry representatives. Committees in both chambers are expected to vote on moving the bipartisan proposals to floor votes within two months.
Investigating consumer complaints challenging claims in Twitter and Instagram content that Carb Blocker capsules could stop unused sugars from being stored as fat in the body, Advertising Standards Authority says Protein World breached UK regulations for health and nutrition claims based on the European Union Register of approved claims for foods.
FDA’s proposed rule to revoke soy protein heart health ignores research supporting the claims and cites evidence that isn't compelling, CRN an NPA say in comments to the agency. CRN also submits comments supporting an ingredient firm's petition asking FDA to remove any uncertainty about the of use of pyridoxamine as a dietary ingredient.
UK firm contends processing ingredients into edible form is common across food and nutritional products industries and many foods consumers use regularly contains ingredients that long have been processed for use. Advertising Standards Authority points out a UK Food Standards Agency guidance explained that the use of solvents or other chemicals in processing disqualifies most processed ingredients from labeling as natural.